NCT07321990 Study of the Reproducibility of the French Version of the Modified SMAFRS Scale
| NCT ID | NCT07321990 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut de Myologie, France |
| Condition | SMA |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-07-18 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-07-18 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the test-retest reliability of the French version of the mSMAFRS in adult patients with SMA. The main question\[s\] is to answer if: * ICC is a good estimate of test-retest reliability? * mSMAFRS-F correlate with other outcome measures? Participants will simply answer a french version of the SMA-FRS questionnaire during their routine follow-up visit then again fifteen days later.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Genetically confirmed SMA * Able to comply with all protocol requirements (no significant cognitive impairment) * French-speaking * Affiliated or beneficiary of a social security scheme Exclusion Criteria: * Persons subject to a legal protection measure * Subjects unable to complete the French version of the questionnaire mSMAFRS-Fbecause of lack of French fluency * Subjects unable to complete the French version of the questionnaire mSMAFRS-Fbecause of cognitive impairment * Inability to comply with protocol requirements * Any medical and social conditions that could interfere with the study under theappreciation of the medical coordinator
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07321990 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying SMA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07321990 currently recruiting?
Yes, NCT07321990 is actively recruiting participants. Contact the research team at s.birnbaum@institut-myologie.org for enrollment information.
Where is the NCT07321990 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT07321990 clinical trial?
NCT07321990 is sponsored by Institut de Myologie, France. The trial plans to enroll 60 participants.